
Ugochukwu Onyibo Egolum MD
Heart Failure & Transplantation, Cardiovascular Disease Genetics, Cardiac Critical Care
Physician
Join to View Full Profile
200 S Enota Dr NEGainesville, GA 30501
Phone+1 770-534-2020
Fax+1 770-307-5221
Dr. Egolum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Ugochukwu Egolum, MD, is a distinguished cardiologist based in Gainesville, GA. He specializes in Heart Failure & Transplantation, Cardiovascular Disease Genetics, and Cardiac Critical Care. His subspecialties have been further bolstered by a comprehensive education at Vanderbilt University Medical Center and Howard University College of Medicine. His clinical expertise includes the handling of cardiomyopathies, atrial fibrillation, and heart failure. Dr. Egolum has contributed to the medical field through numerous publications on topics like chronic thrombocytopenia, prescribing patterns for Sodium-Glucose Cotransporter-2 Inhibitors, and more. He also participates in clinical trials, focusing on improving care for heart failure patients.
Education & Training
Vanderbilt University Medical CenterFellowship, Advanced Heart Failure and Transplant Cardiology, 2016
Vanderbilt University Medical CenterFellowship, Cardiovascular Disease, 2013 - 2016
Vanderbilt University Medical CenterResidency, Internal Medicine, 2010 - 2013
Howard University College of MedicineClass of 2010
Certifications & Licensure
GA State Medical License 2017 - 2026
TN State Medical License 2012 - 2018
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. Start of enrollment: 2021 Mar 20
- Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events Start of enrollment: 2021 Jul 08
- Reducing Lung CongestIon Symptoms in Advanced Heart Failure Start of enrollment: 2018 Sep 19
Publications & Presentations
PubMed
- Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter study.Yessar Hussain, Saurabh Malhotra, Brett W Sperry, Francy Shu, Karthikeyan Ananthasubramaniam
Annals of Medicine. 2025-12-01 - Enhanced Sweating - An Innovative Therapeutic Strategy for Managing Decongestion.Sheriff N Dodoo, Ugochukwu Egolum, Jan Biegus
Journal of Cardiac Failure. 2025-10-08 - 5 citationsImpact of Vutrisiran on Functional Capacity and Quality of Life in Transthyretin Amyloidosis With Cardiomyopathy.Farooq H Sheikh, Gilbert Habib, W H Wilson Tang, Julian D Gillmore, Ugochukwu O Egolum
Journal of the American College of Cardiology. 2025-05-27
Press Mentions
A Solution to Help Physicians Take Preventative, Decisive Action Against Heart FailureMarch 4th, 2022
NGMC Barrow, Braselton and Gainesville Receive Accreditation Awards for Stroke, Heart and Diabetes CareAugust 17th, 2023
Northeast Georgia Medical Center Matches New Class of Fellows in Cardiovascular DiseaseDecember 28th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









